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INTRODUCTION 
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CHEMICAL INJURY OF THE EYE 
Chemical injuries are  devastating ocular surface injuries which can 
lead to permanent visual loss. It is mainly by industrial accidents, criminal 
assaults, accidents at home.  The most important agents causing are alkali 
and acid injury. Alkali injuries are more common than acid injuries
1
. Lime 
is the most common alkali injury. Ammonia causes the most severe damage. 
Other alkali are lye, potassium hydroxide and magnesium hydroxide. 
Among acids, sulphuric acid is the most commonly encountered acid injury. 
The most severe acid injury is with Hydrofluoric acid
2
. Other acids 
commonly causing chemical injury are sulphurous, nitrous, acetic, chromic 
and hydrochloric acid.  
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ANATOMY 
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CORNEA 
The adult human cornea is about 11-12 mm horizontally 9-11 mm 
vertically. Its approximately 0.5mm thick in the centre and 0.75mm in 
periphery. It consists of five layers namely corneal epithelium ,Bowman’s 
membrane, stroma, descemets membrane and endothelium. Corneal 
epithelium is continous with the conjunctival epithelium which is composed 
of non-keratinised stratified squamous epithelium .Only the basal cells of 
the corneal epithelium proliferate. Bowmans layer is an acellular membrane 
like zone at the interface between corneal epithelium and stroma. Corneal 
stroma forms more than 90% of the corneal thickness and is responsible for 
cornea physical strength and transparency and stability. There is uniform 
arrangement of collagen fibres in the stroma which is essential for its 
transparency. Stroma also contains spindle shaped keratocytes which are 
similar to fibroblasts .Collagen in corneal stroma is mostly type 
1.Descemets membrane is the basement membrane of corneal endothelium. 
It is mainly made of type IV and type VIII. A single layer of corneal 
endothelial cells covers the posterior surface of descemets membrane in a  
well arranged mosaic pattern. The cell density is about 3500 cells/sq mm. It 
constantly decreases with age
3
. Its main function is to keep the cornea 
dehydrated and thereby maintaining the transparency. 
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LIMBUS 
It is the corneoscleral  junction measuring about 1.5 to 2.0 mm wide. At the 
limbus, the corneal epithelium becomes the bulbar conjunctival epithelium. 
the epithelium in this transition zone contains basal cells which are needed 
for the regeneration of the corneal epithelium.  The epithelium  is thrown 
into folds at this transition zone which increases the surface area. These 
folds are known as the Pallisades of Vogt. The connective tissue within the 
folds contain blood vessels and lymphatics. The Bowman’s membrane of 
cornea becomes continuous with lamina propria of the conjunctiva and the 
fascial sheath of the eyeball, the Tenon’s capsule. The corneal stroma 
becomes the sclera. Descemet’s membrane ends abruptly at schwalbe’s line. 
The corneal endothelium is continuous with the endothelium of trabecular 
meshwork 
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TENON’S CAPSULE 
It is a thin fascial membrane that envelops the eyeball and separates it from 
the orbital fat. The fascial sheath is firmly attached anteriorly to the sclera 
about 1.5mm posterior to the corneoscleral junction. It fuses with the 
meninges around the optic nerve. The ciliary nerves and vessels pierces the 
fascia close to the optic nerve.  
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PATHOPHYSIOLOGY OF CHEMICAL INJURY 
The severity of chemical injury depends on the surface area of contact and 
the degree of penetration
4
. Damage occurs to the conjunctival and corneal 
epithelium, the limbal stem cells, stromal keratocytes, stromal nerve 
endings, endothelium, iris, lens, ciliary body and vascular endothelium of 
the conjunctiva. Acid injuries are more superficial than alkali injuries
5
. 
The major principles guiding the evaluation and treatment of chemical 
injuries are  
1. regeneration of ocular surface epithelium,  
2. stromal matrix remodelling 
3. inflammation 
Epithelial Injury, Repair And Differentiation: 
The centripetal movement of cells from the peripheral cornea , limbus 
and conjunctiva is responsible for normal and posttraumatic replacement of 
corneal epithelium
6
. The presence of limbal stem cells maintains and 
replaces injured corneal epithelium. The migrated epithelial cells from the 
conjunctival epithelium never fully expresses corneal phenotypic feature
7
. 
Reliance on the conjunctival epithelium to resurface the cornea leads to 
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delayed rehabilitation, deep stromal vascularisation, persistence of globlet 
cells in cornea and poor epithelial basement membrane adhesion. 
Reestablishment of phenotypically normal corneal epithelial surface with 
limbal stem cell derived cell population is the major principle of treatment 
of severe chemical injury.  
 
Corneal stromal matrix injury, repair & ulceration: 
The primary response of keratocytes is to maintain & regeneration of 
stroma.  After chemical injury, degeneration of the basement membrane 
collagen and corneal stromal is initiated by various matrix metalloproteases 
and leads to sterile corneal ulceration
8
. 
 
Inflammation : 
The infiltration of polymorphonuclea leukocytes into the corneal 
stroma with sterile corneal ulceration causing inflammation and delay in re-
epithelisation and perpetuate continued recruitment of additional 
inflammatory cells.  Rigorous control of inflammation is one of the major 
principles of chemical injury management.  
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CLINICAL COURSE & EVALUATION 
There are four distinct pathological and clinical phases in the course of 
chemical injury:  
1. Immediate  phase 
2. Acute (0-7 days) 
3. Early repair (7-21 days) 
4. Late repair ( 21days  to several months) 
    
Immediate Phase : 
Immediately after the chemical injury, the clinical features are related 
to the depth of penetration and the relative toxicity and concentration of the 
injurious compound.  The size of corneal & conjunctival epithelial defects 
determines the extent and the depth of intraocular penetration and it is 
estimated by corneal clarity, intraocular inflammation, intraocular presence 
& lens clarity.  Limbal stem cell damage is estimated by vascular ischemia 
and necrosis of limbal & bulbar conjunctiva. 
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Acute Phase : 
The important parameters to be monitored in the 1
st
 week are, 
evidence of reepithelisation, intraocular pressure and progressive ocular 
inflammation.  Reepithelisation is mild to moderate chemical injuries but 
absent in severe chemical injury.  Intraocular pressure may raise due to 
trabecular meshwork distortion and release of prostaglandins and may 
remain elevated due to persistent inflammation.  
 
Early repair phase : 
The epithelial migration occurs in early repair phase in mild and 
moderate injuries but is delayed in severe chemical injuries.  In severe 
chemical injuries a second wave of infiltration of inflammatory cells begin 
after 7 days and continues to progress over the next several weeks and there 
is persistence of corneal & conjunctival epithelial defects and limbal 
ischemia. 
 
Late Phase : 
When the late repair phase begins, corneal inflammation, collagen 
synthesis and collagenase activity are peaking
9
. The balance of wound 
repair and collagenolysis is greatly influenced by the status of the corneal 
20 
 
epithelium. in mild limbal injury there is normal re-epithelisation of the 
cornea. In patients with moderate limbal stem cell loss, there is persistence 
of epithelial defect corresponding to the quadrant of limbal stem cell loss. 
Further it may lead to re-epithelisation with conjunctival epithelial cells 
which is associated with superficial pannus. The absence of re-epithelisation 
in this stage indicates complete limbal stem cell loss. If the proximal 
conjunctiva is normal, then the cornea heals with total vascularised pannus. 
In patients with complete loss of limbal stem cell loss and the promimal 
conjunctival epithelium with ischemic necrosis, there occurs sterile corneal 
ulceration and perforation.  
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CHEMICAL 
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DUA’s CLASSIFICATION OF CHEMICAL INJURY 
 
 
Grade 
Clinical 
findings 
Conjunctival 
involvement 
Prognosis 
I 
0 clock hours of 
limbal involvement 
0% Very good 
II 
<3 clock hours of 
limbal involvement 
<30% Good 
III 
>3–6 clock hours of 
limbal involvement 
>30–50% Good 
IV 
>6–9 clock hours of 
limbal involvement 
>50–75% Good to guarded 
V 
>9–<12 clock hours 
of limbal 
involvement 
>75–<100% Guarded to poor 
VI 
Total limbus (12 
clock hours) 
involved 
Total conjunctiva 
(100%) involved 
Very poor 
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TREATMENT 
 
IMMEDIATE TREATMENT 
Neutralisation of the pH and removal of the remaining debris by 
copious irrigation with any non toxic irrigating solution for a minimum of 
30 minutes prevents further damage to the ocular surface. Debridement of 
the necrotic corneal epithelium is needed for proper re-epithelisation and 
healing. The limbal stem cells are placed in the deep location, and hence 
prompt removal of the debris can prevent permanent damage
10
. Double 
eversion of the upper eyelid and removal of the debris deposited in the 
upper tarsal conjunctiva should be done to prevent continued slow release of 
the chemical into the tear film. Debridement of the necrotic conjunctiva 
should be done as its a source of inflammatory cells and proteolytic 
enzymes
11
.  
 
Medical therapy 
Promotion of epithelial wound healing 
The rate-limiting factor in the healing of the chemical injury is the 
recovery of intact normal epithelium. Re-epithelisation is facilitated by 
25 
 
initial aggressive medical management. In severe injuries surgical treatment 
should be planned as medical management alone will not be adequate. 
Tear substitutes: 
In chemical injury, unpreserved tear substitutes are used to facilitate 
reepithelialization. Topical viscoelastics are used to facilitate 
reepithelialization in severe chemical injuries. It facilitates corneal epithelial 
migration in grade I and II injuries and minimizes conjunctival scarring and 
after grade III and IV injuries it prevents symblepharon formation. 
 
Frequent application of unpreserved tear substitutes and ointments at 
bedtime after reepithelialization is necessary to prevent recurrent epithelial 
erosions and persistent keratopathy . 
 
Occclusive Therapy: 
Patching of the eyelids protects the migrating epithelial cells in the 
immediate phase.  The cause of epithelial defects in the early and late repair 
phases is persistent inflammation and limbal stem-cell deficiency which are 
unresponsive to occlusive therapy. 
 
Bandage Soft contact lens: 
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Therapeutic soft contact lenses and collagen shields are poorly 
tolerated in the acute phase and there is no advantage to using it in treatment 
of the management of a persistent epithelial defect as it is due to persistent 
inflammation and limbal stem-cell deficiency
11
. 
 
Autologous Serum: 
In clinical trials topical fibronectin and epidermal growth factor  
helped in promoting reepithelialization. Autologous serum is prepared in 
clinical laboratories and are not commercially available.   
 
SUPPORT REPAIR AND MINIMIZE ULCERATION 
Ascorbic acid: 
Vitamin C is a water-soluble vitamin and it is a cofactor in the rate-
limiting step in collagen synthesis.  There is decrease in secretion of 
ascorbate and a reduction in its concentration in the anterior chamber 
following damage to the ciliary body epithelium
12
. Vitamin C deficiency 
leads to impaired collagen synthesis in keratocytes.  Although both systemic 
and topical ascorbate application  have shown to reduce the occurrence of 
sterile corneal ulceration following chemical injury, topical application is 
superior.  It has no effect after the stromal ulceration is established. 
27 
 
Collagenase Inhibitors: 
Collagenase inhibitors like cysteine, acetylcysteine, sodium, calcium 
EDTA, and penicillamine prevents corneal stromal melting in severe 
chemical injuries.  The disadvantage of  collagenase inhibitors are poor 
corneal penetration, weak potency and instability
13
. 
 
Tetracycline derivatives have collagenase activity due to chelation of 
zinc at the active site of the collagenase enzyme.  The most potent 
tetracycline collagenase inhibitory activity  is Doxycycline
14
. 
 
CONTROL OF INFLAMMATION 
Corticosteroids: 
In acute and chronic inflammation the mainstay of treatment to 
reduce the tissue injury is Corticosteroids. Fear of the fact that re-
epithelialization may be delayed and sterile corneal ulceration may occur 
following use of corticosteroids has resulted in a reluctance to use it in the 
acute phase.  
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Corticosteroids do not affect the rate of epithelial wound healing and 
it also decreases the inflammatory cell infiltration, which facilitates 
indirectly corneal epithelial migration and suppress sterile ulceration
15
.  
Corticosteroids  do impair keratocyte migration and collagen synthesis and 
interfere with stromal repair
16
 . 
 
Corticosteroid  use is successful in the first 7-10 days following 
chemical injury. Monitoring of corneal thinning should be done and steroids 
should be tapered. Later progestational steroids or  nonsteroidal anti-
inflammatory drugs (NSAID) can be used when corticosteroid related 
complications are more likely.  
 
Progestational Steroids: 
Medroxyprogesterone 1%  has less anti-inflammatory potency than 
corticosteroids but has less deleterious effect on stromal repair and collagen 
synthesis.  Medroxyprogesterone inhibits collagenase and reduces sterile 
ulceration after chemical injury
17
. It also suppresses corneal 
neovascularization. It is started after 10-14 days as a substituition to 
corticosteroids, as suppression of inflammation still is required,  without the 
deleterious effect on stromal repair.  
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NSAIDs: 
  NSAIDs are an additive for corticosteroids in the first week and a 
substitute or additive for steroids later.  The effect of NSAIDs wound repair, 
collagen synthesis, collagenolysis, and inhibition of neovascularisation is 
not yet clear. 
 
SURGICAL THERAPY 
Surgical intervention in the early phase is with Tenon’s  
advancement, amniotic membrane transplantation, with or without limbal 
stem cell transplantation to achieve successful corneal re-epithelialization. 
Late surgical interventions available are penetrating or lamellar 
keratoplasty, for visual rehabilitation and structural integrity. 
 
The identification of the role of stem cells in the regeneration and 
maintenance of the ocular surface is the most important advancement in the 
treatment of chemical injury
18
. The application of this knowledge in ocular 
surface transplantation techniques helps to specifically deal with stem cell 
loss and structural abnormalities at each phase of  severe chemical injuries . 
Ocular surface transplantation techniques like conjunctival and Tenon’s 
advancement (tenoplasty),  promote epithelial wound healing, helps in 
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reestablishment of limbal vascularity and provides source of epithelium for 
the denuded corneal surface
19
. Amniotic membrane grafting increases the 
migration of surviving limbal stem cells. For reestablishment of limbal stem 
cells, limbal stem-cell transplantation can be done. Mucosal membrane 
transplantation is used to form the conjunctival fornices and normal 
apposition of  lid and globe.  For the success of corneal transplantation for 
visual rehabilitation, reestablishment of normal corneal epithelium and 
normal conjunctival fornix and lid-globe relationships is essential.  
 
TISSUE ADHESIVE : 
 
Tissue adhesive are useful in preventing further progression of sterile 
corneal ulceration. It is also used in maintaining the integrity of  the globe, 
when other measures have failed.  It is best for use for impending or actual 
perforations, that are 1mm or smaller in size and it is preferred to 
emergency tectonic procedures.  A tectonic penetrating keratoplasty may be 
used to preserve the integrity of the globe for perforations that are (>1 mm) 
that cannot be adequately addressed with tissue adhesive. After 6-8 weeks 
the tissue adhesive may be removed or allowed to extrude spontaneously, 
when a stable fibrovascular scar has formed and when the risk of subsequent 
stromal ulceration is eliminated.  This fibrovascular scar may impair vision 
31 
 
and worsen the prognosis for subsequent penetrating keratoplasty 
unfortunately. 
 
AMNIOTIC MEMBRANE TRANPLANTATION: 
Human amniotic membrane is the thin, innermost layer of the 
placenta.  It consists of an epithelial monolayer, an avascular stromal matrix 
and a thick basement membrane.  The tissue may be transplanted with the 
basement membrane upward or downwards to the corneal surface. The 
amniotic membrane behaves like a biological bandage contact lens when 
used with the basement membrane oriented downwards thereby promoting 
epithelialization under the membrane
20
.   It dissolves earlier than desired 
before reepithelialization is complete.  When it is used with basement 
membrane oriented upward, then it behaves like an inlay graft, with the 
amniotic membrane functioning as a new basement membrane which 
promotes epithelialization over its surface
21
.  It becomes incorporated into 
the substratum of the newly formed epithelium and persists for months. But 
it does not always possess the same transparency of healthy stroma.  It can 
also be used with a combination of an inner amniotic membrane with the 
basement membrane oriented upward and an outer amniotic membrane with 
the basement membrane oriented downward and the  reepithelialization is 
‘sandwiched’ between two basement membranes. 
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Irrespective of the transplantation technique, reepithelialization is 
facilitated by amniotic tissue if complete or partial limbal stem-cell  
function is present.  Reepithelialization is improved by providing a 
basement membrane for initiation of epithelial migration and adhesion and 
it also releases growth factors that facilitate proliferation of limbal stem 
cells and transient amplifying cells.  Amniotic tissue by excluding 
inflammatory cells from the corneal stroma can reduce inflammation  and  it 
also releases factors that suppress proinflammatory cytokines, facilitate 
apoptosis of inflammatory cells, and reduce epithelial and keratocytes 
apoptosis. It also reduces corneal neovascularisation and conjunctival scar 
formation after chemical injury.  
 
The use of amniotic membrane in the treatment of ocular surface 
disease  was reintroduced by Kim and Tseng in 1995.   Treatment of acute 
phase grade II and III injuries with both onlay and inlay graft techniques 
results in successful reepithelialization.  
 
In the treatment of grade IV injuries, disappointing results have been 
reported, due to total limbal stem-cell loss. 
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Amniotic membrane transplantation may be used in the late 
rehabilitation phase, either alone or in conjunction with limbal stem-cell 
transplantation. It is effective in cases of persistent epithelial defects, 
recurrent epithelial erosions, and in the reduction of chronic inflammation.  
It is also combined with reconstructive procedures of the ocular surface like 
symblepharon lysis. In cases of complete limbal stem-cell function, it is 
used as adjunctive with limbal stem-cell transplantation. 
 
LIMBAL STEM-CELL TRANSPLANTAION 
Kenyon and Tseng developed limbal stem-cell transplantation as a 
modification of  Thoft’s original conjunctival transplantation technique
22
.  
In the clinical course of a grade III or IV injury it is the best method of 
reestablishing a phenotypically correct corneal epithelial surface and 
preventing the problems of fibrovascular pannus or sterile corneal 
ulceration.  In addition, this procedure may be performed later in the clinical 
course in order to improve ocular surface function. It can also be a part of a 
staged procedure with penetrating keratoplasty to provide visual 
rehabilitation. 
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In unilateral or asymmetric cases of chemical injury, conjunctival 
limbal autograft transplantation (CLAU) is usually performed by harvesting 
contralateral limbal stem cells from the unaffected or less injured fellow eye 
and transferring them to the affected or more injured eye.  Ipsilateral CLAU 
is an option for treatment of limited sectorial limbal stem-cell deficiency, 
where the transfer of tissue from an unaffected area in the opposite meridian 
of the damaged limbus to the ischemic area is done
23
. 
 
Limbal allograft transplantation from a relative or a cadaver donor are 
the only viable options in cases of severe bilateral injures.  The procedure of  
Living-related conjunctival limbal allograft transplantation (Ir-CLAG) is 
technically same as CLAU with the exception that the limbal stem cells are 
harvested from a close relative and transferred to the injured eye
24
.  The risk 
of graft rejection is higher after this procedure than with keratoplasty mostly 
due to the transplantation of vascular tissue into a vascular bed and a higher 
concentration of transplanted antigens in the peripheral cornea.  
 
The use of prolonged topical and systemic immunosuppression 
prevents rejection and maintenance of a stable stem cell population.  Use of  
topical corticosteroids and cyclosporine indefinitely or triple 
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immunosuppressive therapy with tapering doses of prednisone, cyclosporine 
A, and azathioprine for a minimum of 12-24 months are recommended. 
Rejection rates as high as 25-33%
  
have been reported despite systemic 
immunosuppression. Keratolimbal allograft transplantation (KLAT)is used 
for transferring the limbal stem cells from a donor cadaver for treatment of 
severe bilateral chemical injuries.  The risk of graft rejection is very high, 
but with prolong, aggressive topical and  systemic immunosuppression 
successful preservation of limbal stem-cell function and corneal clarity has 
been reported  
 
 
Expansion of limbal stem cells ex vivo is being investigated as an 
improvement of existing limbal stem-cell transplantation techniques.  In this 
procedure, the small piece of donor limbal tissue is dissected and placed in a 
cell culture. After the  growth and expansion of viable limbal stem cells in 
culture, transplantation of the epithelial sheet to the recipient eye is 
performed.  The technical difficulties in cell culture and transfer of the 
epithelial sheet to the recipient eye are the limitations in the application of 
this technique. In future it will be possible to restore the function in all cases 
of severe bilateral injuries by autograft transplantation, without the risk of 
immunological rejection.  If antigen-presenting Langerhan’s cells are 
36 
 
eliminated during cell culture  and if only epithelial cells are transplanted in 
cases where harvesting of limbal stem cells is required from a living relative 
or a cadaver, the risk of rejection will be reduced. 
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MUCOSAL MEMBRANE TRANSPLANTATION 
Progressive scarring of the bulbar and palpebral conjunctiva leads to 
mechanical abnormalities like restriction of extraocular movement, fornix 
foreshortening and obliteration, symblepharon formation and lid 
abnormalities like incomplete lid closure, cicatricial entropion, trichiasis, 
and lid margin keratinization. Bulbar conjunctival transplantation in 
unilateral cases can correct most of these abnormalities. In bilateral cases 
use of mucosal membrane grafts to reconstruct the fornix and restore normal 
lid-globe relations, prevents the above mentioned complications.  But they 
do not restore the corneal epithelial functions following  limbal stem-cell 
transplantation. The impaired goblet cell function of the conjunctiva  can be 
improved by harvesting  mucosal grafts from nasal mucosa. 
PENETRATING KERATOPLASTY 
After the rehabilitation of the ocular surface has been achieved, an 
optical penetrating keratoplasty may be attempted
25
. Performing limbal 
stem-cell transplantation prior to penetrating keratoplasty or doing the 
procedures simultaneously may facilitate more rapid visual rehabilitation.  
The prognosis for successful penetrating keratoplasty depends on the 
original severity and sequelae of the chemical injury and the adequacy of 
restoration of normal ocular surface. 
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Kuckelkorn and Redbrake have reported success with large-
diameter(11 to 12mm) penetrating  keratoplasty in both the acute and 
chronic chemical injuries
26
.  In the acute setting, penetrating keratoplasty is 
highly successful in the management of impending or actual corneal 
perforation, but in the long-term prognosis for graft clarity is poor. When 
the procedure is done for combined late rehabilitation of persistent limbal 
stem-cell dysfunction and corneal opacification, the prognosis for graft 
survival is poor, mainly because of the allograft rejection of the donor 
limbal stem-cells, rather than endothelial rejection. 
 
KERATOPROSTHESIS 
Kerotoprosthesis may be useful in bilateral, several chemical injury 
with irreparable damage to the ocular surface in which the prognosis is 
hopeless for penetrating keratoplasty. It can also be tried in unilateral cases 
with repeated immunologic endothelial rejection. The success rate of 
keratoprosthesis has been poor in the past. The success rate has improved 
following improved Keratoprosthesis design and better postoperative 
management available now. 
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TENOPLASTY 
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TENOPLASTY / POSTERIOR TENON’S ADVANCEMENT 
Due to severe limbal ischemia in eyes with chemical injury, persistent 
conjunctival or corneal defect develop and there is high risk of perforation. 
The surgical approach of bringing back the blood supply to the ischemic 
area by placing the vital connective vascular tissue of the orbit, is described 
in 1989 by Teping C and Reim M and is known as tenon’s advancement or 
tenoplasty
27
.  The following surgical technique  uses an amniotic membrane 
as a substrate for the relocation of vital vascular tenon sheet. 
 
Surgical Technique : 
A peritomy is done to separate the necrotic tissue from the remaining 
healthy conjunctiva with the help of corneal scissors. The necrotic tissue is 
dissected and removed with corneal scissors. After the removal of necrotic 
tissue, a free pedicle tenon vascular sheet is dissected from the deep 
posterior part of the unburned area.  It is done by creating a plane by 
between the conjunctiva and the subconjunctival fibrovascular tissue using 
0.12 forceps, and this plane can be further dissected  to separate the 
conjunctiva from the subconjunctiva,  by using scissors.   After the 
separation of the conjunctival layer from the subconjunctival tissue, a 
second plane is identified between the deep tenon layer and subconjunctival 
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fibrovascular tissue by scissors. A free vascular pedicle graft can be moved 
from the posterior pole towards the limbus.  Once an adequate size of 
pedicle tenon vascular sheet obtained, the bare sclera is protected by using a 
layer of amniotic membrane with the stromal side face down and it is 
anchored to the sclera by using interrupted 8-0 Vicryl sutures at the 
conjunctiva and 10-0 nylon at the limbus along with episcleral bites.  The 
free pedicle vascular tenon sheet is placed over the amniotic membrane and 
secured to it with interrupted 8-0 Vicryl sutures with episcleral bites  and a 
second layer of amniotic membrane is used to cover the vascular tenon sheet 
and secured with 10-0 nylon at the limbus and with 8-0 Vicryl sutures at the 
conjunctiva.  The amniotic membrane is secured to the conjunctiva and to 
the lid margin with the stromal or sticky side facing down by using 8-0 or 9-
0 Vicryl sutures with episcleral bites.  At the lower and upper fornices the 
amniotic membrane is further secured with two double-arm 4-0 silk sutures, 
which are brought through the lid and tied over the skin with bolsters. At the 
end, the entire ischemic area is protected by a sandwiched vascular tenon 
sheet with two amniotic membrane grafts. 
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OBJECTIVES 
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AIMS AND OBJECTIVES 
 
 The aim of the study is to study the following parameters 
1. The effect of tenoplasty in healing of severe chemical injury 
2. The effect of tenoplasty in improvement of limbal ischemia 
3. The effect of tenoplasty in preserving the ocular surface integrity 
4. The clinical presentation and course of severe chemical injury 
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PATIENT SELECTION 
INCLUSION CRITERIA: 
 All patients with severe chemical injuries (acid and alkali injuries) – grade 
IV and above by DUA Classification 
 
Duration of the study - 2 years  
                    
EXCLUSION CRITERIA: 
                                 
1. Patients with corneal perforation  
2. Patient mild chemical injury (grade III and less by DUA classification)  
3. Patients with infected corneal ulcers following chemical injury 
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DUA’s CLASSIFICATION OF CHEMICAL INJURY 
 
 
 
Grade 
Clinical 
findings 
Conjunctival 
involvement 
Prognosis 
I 
0 clock hours of 
limbal involvement 
0% Very good 
II 
<3 clock hours of 
limbal involvement 
<30% Good 
III 
>3–6 clock hours of 
limbal involvement 
>30–50% Good 
IV 
>6–9 clock hours of 
limbal involvement 
>50–75% Good to guarded 
V 
>9–<12 clock hours 
of limbal 
involvement 
>75–<100% Guarded to poor 
VI 
Total limbus (12 
clock hours) 
involved 
Total conjunctiva 
(100%) involved 
Very poor 
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PRE-OPREATIVE SCREENING PROCEDURES 
 
Patients are screened for Visual acuity by Snellen’s chart , intraocular 
pressure evaluation by schiotz tonometer or noncontact tonometer,  Slit 
lamp examination, Fundus examination, Blood pressure, glycemic indices 
like serum glucose levels and urine- alb/sugar. 
 
 
POST-OPERATIVE VISITS 
 
Patients are reviewed on the 1
st
 post operative day, then on everyday 
till the re is epithelial defect healing and the occurrence of limbal 
vasculature. The findings are documented at 1 week and at 1 month.  
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MATERIALS AND 
METHODS 
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MATERIALS AND METHODS 
Patients attending casuality with chemical injury are first given 
copious amount of saline wash with normal saline for thirty minutes. The 
residual chemical debris stuck on to cornea and conjunctiva are removed 
with the help of cotton bud or surgical blade. The patients are subjected to 
brief history regarding the time of injury, type of chemical, mode of injury. 
Visual acuity of the patient is documented. The patients are examined in slit 
lamp for the extent of chemical injury and graded based on the amount of 
limbal ischemia in clock hours and amount of conjunctiva exposed in 
percentage of tissue and graded according to dua’s classification.  
 
Medical management with topical steroids like 1%prednisolone 
acetate, lubricant 1% carboxy methylcellose, preservative free antibiotic eye 
drops like moxifloxacin, vitamin c eye drops. Patients are also started on 
oral vitamin c tablets and oral doxycycline for collagenolytic activity. 
Patients with severe chemical injury that is grade 4 or more by dua’s 
classification are taken up for tenoplasty.  
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SURGICAL TECHNIQUE : 
Under local anaesthesia, peritomy is done to separate the necrotic 
tissue from the remaining healthy conjunctiva with the help of corneal 
scissors. The necrotic tissue is dissected and removed with corneal scissors. 
After the removal of necrotic tissue, a free pedicle tenon vascular sheet is 
dissected from the deep posterior part of the unburned area.  It is done by 
creating a plane by between the conjunctiva and the subconjunctival 
fibrovascular tissue using 0.12 forceps, and this plane can be further 
dissected  to separate the conjunctiva from the subconjunctiva,  by using 
scissors.   After the separation of the conjunctival layer from the 
subconjunctival tissue, a second plane is identified between the deep tenon 
layer and subconjunctival fibrovascular tissue by scissors. A free vascular 
pedicle graft can be moved from the posterior pole towards the limbus.  
Once an adequate size of pedicle tenon vascular sheet obtained, the bare 
sclera is protected by using a layer of amniotic membrane with the stromal 
side face down and it is anchored to the sclera by using interrupted 8-0 
Vicryl sutures at the conjunctiva and 10-0 nylon at the limbus along with 
episcleral bites.  The free pedicle vascular tenon sheet is placed over the 
amniotic membrane and secured to it with interrupted 8-0 Vicryl sutures 
with episcleral bites  and a second layer of amniotic membrane is used to 
cover the vascular tenon sheet and secured with 10-0 nylon at the limbus 
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and with 8-0 Vicryl sutures at the conjunctiva.  The amniotic membrane is 
secured to the conjunctiva and to the lid margin with the stromal or sticky 
side facing down by using 8-0 or 9-0 Vicryl sutures with episcleral bites.  At 
the lower and upper fornices the amniotic membrane is further secured with 
two double-arm 4-0 silk sutures, which are brought through the lid and tied 
over the skin with bolsters. At the end, the entire ischemic area is protected 
by a sandwiched vascular tenon sheet with two amniotic membrane grafts. 
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Fig 1 LIMBAL ISCHEMIA 
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Fig 2 CONJUNCTIVAL CHEMOSIS 
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Fig 3 EPITHELIAL DEFECT  
 
 
Fig 4 GRADE VI CHEMICAL INJURY  
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FIG 5 TENOPLASTY 
 
 
FIG 6 AMG OVER TENOPLASTY 
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FIG 7 IMMEDITE POSTOPERATIVE PICTURE 
 
 
FIG 8 SUTURES AT THE LIMBUS 
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FIG 9 SYMBLEPHARON FOLLOWING CHEMICAL INJURY 
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RESULTS 
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RESULTS 
 
Total number of eyes in the study-  20 eyes of 14 patients  
Mean age of the patients – 27.07 years 
TABLE [1]  
SEX RATIO 
Sex Number of patients Percentage 
Male 7 50% 
Female 7 50% 
 
 
SEX RATIO 
Male 
Female 
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TABLE [2] 
 LATERALITY 
Laterlity Number of patients Percentage 
Both eyes 6 42.86 
Right eye 3 21.43 
Left eye 5 35.71 
 
 
 
 
 
LATERALITY 
BE 
RE 
LE 
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TABLE [3]  
MODE OF INJURY 
Mode of injury Number of patients Percentage 
Accidental 8 57.14 
Assault 4 28.57 
Industrial 2 14.28 
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TABLE [4] TYPE OF CHEMICAL 
Chemical Number of patients Percentage 
Acid 8 57.14 
Alkali 6 42.86 
 
 
 
 
 
TYPE OF CHEMICAL 
ACID 
ALKALI 
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TABLE [6]  
MEAN VISUAL ACUITY 
Range of visual acuity 
at presentation 
Number of eyes Percentage 
>5/60 8 40% 
1/60 – 5/60 5 25% 
<1/60 6 30% 
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LIMBAL ISCHEMIA 
TABLE [7]  
MEAN LIMBAL ISCHEMIA 
Limbal ischemia in clock 
hours 
Number of eyes Percentage 
6 9 45% 
7 3 15% 
8 3 15% 
9 2 10% 
10 2 10% 
12 1 5% 
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GRADE OF CHEMICAL INJURY 
IV 
V 
VI 
TABLE [8]  
GRADE OF CHEMICAL INJURY 
Grade of injury Number of eyes Percentage 
IV 13 65% 
V 6 30% 
VI 1 5% 
 
 
Mean time of surgery – 4.6 days 
Epithelial defect was present in all cases 
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TABLE [9] IMPROVEMENT IN VISUAL ACUITY 1 WEEK 
FOLLOWING TENOPLASTY 
Number of lines in 
snellens chart 
Number of eyes Percentage 
Nil 5 25 
=<2 10 50 
>3 4 20 
 
TABLE [10] IMPROVEMENT IN VISAUL ACUITY IN VARIOUS 
GRADES OF CHEMICAL INJURY 
 
 
 
Number of lines 
improvement in visual 
acuity  
Grade IV Grade V Grade VI 
0 1 2 0 
1-2 8 2 0 
3-6 4 1 1 
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TABLE [11] IMPROVEMENT OF LIMBAL ISCHEMIA AT 1
ST
 
WEEK POST-OP 
Improvement in 
limbal ischemia in 
clock hours 
Number of eyes Percentage 
4 3 15 
5 2 10 
6 11 55 
7 2 10 
8 2 10 
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TABLE [12]  
IMPROVEMENT IN VISUAL ACUITY AT 1 MONTH POST-OP 
Number of lines 
improvement in visual 
acuity 
Number of eyes Percentage 
0 3 15% 
=<2 6 30% 
>3 10 50% 
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IMPROVEMENT IN LIMBAL ISCHEMIA AT 1 MONTH POST-OP 
At the end of one month all patients of grade IV and grade V had no 
residual limbal ischemia. One patient belonging to grade VI chemical injury 
developed residual limbal ischemia at the end of one month 
 
SYMBLEPHARON FORMATION  
Symblepharon formation was found in one patient(5%) of the study 
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DISCUSSION 
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DISCUSSION 
 
Our study was conducted in a tertiary eye care in south india, from 
august 2010 to September 2012, included 20 eyes of 14 patients. The mean 
age of presentation of our study group was 27.07 years which included two 
pediatric patients also. It was similar to the Adepoju et al where the mean 
age of the study group was 31.87 years, emphasising the prevalence of 
chemical in the young working population
28
. 
 
 In our study the male-female preponderance was equal in both the 
groups. But most of other studies like Adepoju et al
28
 and Le et al
29
, showed 
more male preponderance as they included all grades of  chemical injuries 
whereas in our study only the severe chemical injury patients were enrolled. 
 
 In our study, 57% of patients the mode of chemical injury was 
accidental. 28% of patients developed chemical injury by assault and 14% 
of injuries were industrial accidents. In other studies like Xie et al, majority 
of the chemical injuries were occupational
30
. Even in our study most of the 
accidental injuries were due to household cleaning acid.  
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In our study 42.1% of patients had bilateral chemical injuries. Among 
the unilateral cases the prevalence of left eye injuries were more than right 
eye injuries. Other studies like Saini et al
31
 also show similar bilateral 
involvement with 42.9%. In our study, acid injuries (57%) were slightly 
more common than alkali injuries(43%). Other studies like Tejwani et al, 
showed more prevalence of alkali injuries
32
.  
  
In our study which dealt only with severe chemical injuries, 40% of 
the eyes had visual acuity of =or>6/60. 20% of the eyes had visual acuity of 
the range 1/60 -5/60 by Snellens chart. 35% of the patients had visual acuity 
<1/60.   The maximum visual acuity of the patient enrolled was in two 
patients with  6/18, both of them had 6 clock hours of limbal ischemia. The 
minmum visual acuity of the patient in the study was PL in two patients 
with total limbal ischemia with cataract and they did not improve following 
tenoplasty.  In the study by Adepoju et al
28
 ,33.3% of patients had vision 
<3/60 which is similar to our study. 
 
 In our study patients were classified based on Dua’s classification 
which classifies patient based on limbal ischemia and area of conjunctival 
involvement. Limbal ischemia and conjunctival chemosis represent the 
amount of exposure to the chemical and hence they have prognostic value. 
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Gupta et al showed that, Dua classification by providing further 
subclassification of grade IV chemical injuries by Roper Hall into three 
separate grades has a superior prognostic predictive value in severe 
chemical injuries
33
. 
 
In our study 13 eyes(65%) belonged to grade IV, 6 eyes had grade V 
clinical features and one eye had grade VI clinical features of limbal 
ischemia and conjunctival involvement. Tenoplasty was done in all patients. 
Two eyes of two pediatric patients were taken for surgery under general 
anaesthesia and the rest of the patients were operated in peribulbar block.  
  
The mean time of delay in surgical treatment was 4.6 days. Earliest 
surgery was done on the same day of the injury in a grade IV acid injury 
patient, who on follow up had complete regression of limbal ischemia. 
Maximum delay in surgery for the primary eye was 7 days, in both the 
pediatric patients due to the delay in obtaining fitness for general 
anaesthesia, and in one patient with grade VI acid injury, the delay was due 
to uncontrolled diabetes.  
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At the end of one week post-op, among the eyes with grade IV 
chemical injury(13), in 1 patient(7.6%) there was no improvement in visual 
acuity, 8 eyes(61.5%) had <3 line improvement in snellens chart and 4 eyes 
had >2 line improvement in visual acuity, the maximum being 5 line 
improvement in one patient. In eyes with grade V injuries(5), 2(40%) eyes 
had no visual improvement , 2(40%) eyes had <3 line visual acuity 
improvement and 1(20%) patient had >2 line improvement in visual acuity. 
One of a patient had grade VI in the study and she didnot show any 
improvement in visual acuity in 1
st
 week.  
 
The improvement in limbal ischemia in the study at the end of one 
week post-operative period was as follows. 16(80%) eyes had improvement 
in limbal vascularisation of < or= 6 clock hours, 4(20%) eyes had 
improvement >6 clock hours. 9 (69.3%) out of 13 eyes with grade IV injury 
did not have residual ischemia at the end of one week. In 5 eyes with grade 
V injuries 2 eyes had residual limbal ischemia of 2 clock hours and in 3 
patients, of more than 3 clock hours. In one eye with grade VI injury the 
residual limbal ischemia was 6 clock hours.  
 
At the end of one month, in 13 eyes grade IV injuries, improvement in 
visual acuity = or>3 lines was seen in 8(61.5%) patients, 4 eyes had visual 
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acuity improvement of <3 lines, and one eye had no improvement in visual 
acuity due to development of cataract. These findings were similar to the 
results obtained at 1
st
 week postoperative period.  
 
All patients of grade IV and V chemical injury had no residual limbal 
ischemia or ocular surface abnormality at the end of one month. One patient 
who presented with grade VI injury had a residual ischemia of 4 clock hours 
with symblepharon formation. In a study done by Tamhane et al with only 
amniotic membrane transplantation there was no overall difference in the 
final visual acuity, symblepharon formation, corneal vascularization, and 
tear function tests between medical treatment and amniotic membrane 
grafting
34
. Sharma et al showed improvement in visual acuity and 
preservation of ocular surface integrity with the help of tenoplasty with 
cyanoacrylate glue
35
. In another study done by Kuckelkorn R et al on 
tenoplasty for severe chemical injuries, in all patients, corneoscleral 
ulceration was prevented and ocular surface integrity was maintained
36
. 
Thus amniotic membrane transplantation alone improves the corneal 
epithelial healing but has no improvement in limbal stem cell deficiency, 
whereas tenon’s advancement improves the limbal vasculature and prevents 
corneoscleral ulceration and maintains the integrity of the globe for future 
optical keratoplasty. 
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SUMMARY 
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SUMMARY 
A total of 20 eyes of 14 patients were included in our study with severe 
chemical injury based on Dua’s classification. All patients underwent 
tenoplasty. The area of limbal ischemia, conjunctival involvement, visual 
acuity and other associated complications were noted.  
 The mean age of presentation of our study group was 27.07 years  
 
 The male-female preponderance was equal in both the groups in the 
study. 
 
 The mode of injury in our study was, 57% of patients the mode of 
chemical injury was accidental. 28% of patients developed chemical 
injury by assault and 14% of injuries were industrial accidents. 
 
 Most of the accidental injuries were due to household cleaning acid.  
 
 42.1% of patients had bilateral chemical injuries 
 
 In the unilateral cases the prevalence of left eye injuries was  more 
than right eye injuries 
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 Acid  injuries (57%) were slightly more common than alkali 
injuries(43%). 
 
 At the time of presentation, 40% of the eyes had visual acuity of 
=or>6/60. 20% of the eyes had visual acuity of the range 1/60 -5/60 
by Snellens chart. 35% of the patients had visual acuity <1/60.  
 
 By Dua’s classification, 65% belonged to grade IV, 30% of eyes had 
grade V clinical features and 5%  had grade VI. 
 
 The mean time of delay in surgical treatment was 4.6 days 
 
 At the end of one week post-op, among the eyes with grade IV 
chemical injury 61.5% had <3 line improvement in snellens chart and 
30.75% eyes had >2 line improvement in visual acuity 
 
 In eyes with grade V injuries 40% eyes had no visual improvement , 
40% eyes had <3 line visual acuity improvement and 20% eyes  had 
>2 line improvement in visual acuity 
 
 The patient belonging to grade VI chemical injury in the study,  
didnot show any improvement in visual acuity in 1
st
 week 
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 At the end of one week post-operative period, 80% eyes had 
improvement in limbal vascularisation of < or= 6 clock hours, 20% 
eyes had improvement >6 clock hours. 
 
 69.3% of eyes with grade IV injury did not have residual limbal 
ischemia at the end of one week, whereas the eye with grade VI 
injury the residual limbal ischemia was 6 clock hours. 
 
  At the end of one month, in eyes with grade IV injuries, 
improvement in visual acuity = or>3 lines was seen in 61.5%. 
 
 The results of improvement in visual acuity at one month were 
similar to the results at one week.  
 
 The patient who presented with grade VI injury had a residual 
ischemia of 4 clock hours with symblepharon formation. 
 
  All patients of grade IV and V chemical injury had no residual limbal 
ischemia or ocular surface abnormality at the end of one month. 
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CONCLUSION 
 
Chemical injuries are one of the devastating cause of permanent 
visual loss in the young working population. By producing limbal ischemia 
and limbal stem cell deficiency, the chance of corneoscleral ulceration is 
common. It requires immediate and prompt medical and appropriate 
surgical intervention to prevent the permanent complications. 
 
Our study shows that surgical intervention by tenoplasty in severe 
chemical injuries, improves the limbal ischemia and prevents corneoscleral 
ulceration and gives us a chance for future optical keratoplasty for visual 
rehabilitation.   
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PROFORMA 
S.NO. 
NAME 
AGE 
SEX 
LATERALITY 
MODE OF INJURY 
CHEMICAL 
CLINICAL FEATURES  
1. VISUAL ACUITY 
2. LIMBAL ISCHEMIA 
3. CONJUNCTIVAL CHEMOSIS 
4. GRADE OF INJURY BY DUA CLASSIFICATION 
5. CORNEAL EPITHELIAL DEFECT 
6. INTRAOCULAR PRESSURE  
7.  FUNDUS EXAMINATION 
8.  BLOOD PRESSURE  
9. SERUM GLUCOSE LEVELS AND  
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10. URINE- ALB/SUGAR. 
TIME OF TENOPLASTY 
1ST WEEK POST-OP 
1. VISUAL ACUITY 
2. LIMBAL ISCHEMIA 
3. CORNEAL EPITHELIAL DEFECT 
4. SYMBLEPHARON 
5. LID ABNORMALITIES 
6. INTRAOCULAR PRESSURE 
 
1ST MONTH POST-OP 
1. VISUAL ACUITY 
2. LIMBAL ISCHEMIA 
3. CORNEAL EPITHELIAL DEFECT 
4. SYMBLEPHARON 
5. LID ABNORMALITIES 
6. INTRAOCULAR PRESSURE 
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KEY TO MASTER CHART 
M – Male 
F – Female 
RE – Right eye 
LE – Left eye 
BE – Both eyes 
Limbal ischemia – in clock hours 
Conjunctival chemosis – in % 
PL – Perception of light 
HM – Hand movements 
S – Symblepharon 
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1 Kalaicharan 20 M RE industrial acid  6/18 6 50 4 P 3 6/12 No No 6/6 No No 
2 Seetha 40 F LE Assault acid  PL 12 100 6 P 7 PL 6 P HM 4 s 
3 Poornima 5 F RE Accidental Alkali 6/60 7 60 4 P 7 6/36 2 p 6/12 No No 
4 Jaswant 3 M RE Accidental Alkali   9 80 5 P 7   3 P   No No 
5 Joseph 43 M LE Accidental acid  HM 6 60 4 P 6 HM No No HM No No 
6 Selvi 38 F LE Assault acid  HM 10 100 5 P 3 HM 2 p HM No No 
7 Selvi 38 F RE Assault acid  6/60 8 90 4 P 5 6/36 No No 6/36 No No 
8 Baskar 27 M LE Accidental Alkali 6/24 6 50 4 P 3 6/18 No No 6/12 No No 
9 Baskar 27 M RE Accidental Alkali 6/18 6 50 4 P 5 6/12 No No 6/9 No No 
10 Selvaraj 20 M RE Accidental acid  1/60 8 90 5 P 3 5/60 2 P 6/36 No No 
11 Selvaraj 20 M LE Accidental acid  3/60 6 70 4 P 5 6/60 No NO 6/18 No No 
12 Ravi  42 M LE Assault acid  HM 9 90 5 P 3 2/60 2 No 5/60 No No 
13 Ravi  42 M RE Assault acid  2/60 7 80 4 P 5 3/60 No No 5/60 No No 
14 Janardhanan 37 M RE Assault Alkali PL 10 90 5 P 1 1/60 4 P 2/60 No No 
15 Rama 30 F RE Accidental acid  6/60 6 80 4 P 2 6/60 No No 6/36 No No 
16 meena 20 F LE industrial acid  6/36 6 50 4 P 3 6/12 No No 6/6 No No 
96 
 
 
17 Jothi 38 F LE Accidental acid  HM 8 90 5 P 6 HM 4 P HM No No 
18 Jothi 38 F RE Accidental acid  3/60 6 60 4 p 8 6/60 2 No 6/60 No No 
19 Pushpa 16 F RE Accidental Alkali 5/60 7 80 4 P 3 6/60 2 p 6/18 No No 
20 Pushpa 16 F LE Accidental Alkali 6/60 6 60 4 P 7 6/36 2 p 6/12 No No 
